Compare FORM & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FORM | AMRX |
|---|---|---|
| Founded | 1993 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.8B |
| IPO Year | N/A | N/A |
| Metric | FORM | AMRX |
|---|---|---|
| Price | $56.25 | $12.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $55.75 | $13.25 |
| AVG Volume (30 Days) | 654.7K | ★ 1.7M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.53 | 0.02 |
| Revenue | $759,313,000.00 | ★ $2,934,959,000.00 |
| Revenue This Year | $3.97 | $9.99 |
| Revenue Next Year | $10.24 | $6.67 |
| P/E Ratio | ★ $104.87 | $758.81 |
| Revenue Growth | 2.29 | ★ 9.50 |
| 52 Week Low | $22.58 | $6.69 |
| 52 Week High | $61.10 | $12.68 |
| Indicator | FORM | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 57.28 | 61.79 |
| Support Level | $54.96 | $12.12 |
| Resistance Level | $60.30 | $12.43 |
| Average True Range (ATR) | 1.95 | 0.31 |
| MACD | -0.25 | -0.04 |
| Stochastic Oscillator | 56.44 | 70.61 |
FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.